Apotex Health Corp. (APTX.TO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

+345.4%

CA$149.70

vs CA$33.61 price

Levered DCF

CA$37.84

After debt service

Piotroski score

—

Altman Z-score

—

Rating

—

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023
P/E	16.77×	40.91×	-42.19×
P/B	-11.21×	21.23×	8.42×
P/S	1.79×	1.84×	2.1×
EV / EBITDA	10.66×	13.08×	47.07×
Gross margin	55.6%	53.6%	37.5%
Operating margin	22.5%	16.5%	-0.2%
Net margin	10.7%	4.5%	-5.0%
Current ratio	1.5×	1.39×	1.83×
Debt / equity	-6.31×	9.12×	2.56×
Interest coverage	3.24×	2.5×	-0.03×
Dividend yield	17.7%	2.7%	0.0%
Payout ratio	296.9%	108.1%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023
Return on equity	-67.0%	52.2%	-20.1%
Return on invested capital	17.6%	8.2%	-0.2%
Return on assets	8.2%	3.1%	-3.6%
Free cash flow yield	7.3%	5.0%	7.4%
Earnings yield	6.0%	2.5%	-2.4%
Enterprise value	CA$9.7B	CA$8.7B	CA$7.6B
Net debt / EBITDA	3.8×	3.85×	8.97×
Cash conversion cycle (days)	285	329	288